AI-Based Digital Pathology Shows that Denifanstat Improves Multiple Parameters of Fibrosis and Reduces Progression to Cirrhosis in MASH patients with F2/F3
AASLD The Liver Meeting
8th Annual MASH Drug Development Summit
7th Obesity and NASH Drug Development Summit
NASH and Fibrosis Conference